aiomics is a technology company.
Aiomics is the AI co-pilot for healthcare providers. We capture and structure every piece of patient information, check it for quality, and guide you through compliance, documentation, and communication.
aiomics has raised $2.0M across 1 funding round.
aiomics has raised $2.0M in total across 1 funding round.
Aiomics is a Germany-based healthcare AI startup that builds an AI co-pilot platform to structure unstructured patient data, automate documentation, ensure compliance, and reduce administrative burdens for healthcare providers.[1][2][3][5] It integrates with existing electronic health record (EHR) systems, processes data from paper records, PDFs, and digital files, extracts key details like diagnoses and lab results, flags inconsistencies, and generates compliant reports—saving providers an average of two hours daily while improving patient care quality.[2][3] Targeting hospitals, clinics, and medtech innovators in Europe, aiomics addresses fragmented data and regulatory hurdles like GDPR, MDR, and the EU AI Act, with early traction in telemedicine, rehabilitation, and general practice; it recently secured $2M in pre-seed funding to scale its "Care Triad" connecting providers, patients, and data.[3][4][5]
Aiomics was founded by Dr. Sven Jungmann, a physician with experience in emergency rooms and oncology who witnessed firsthand how paperwork drains clinicians' time and focus, and Dr. Nikita Tarasov, a physicist and data scientist with over a decade building intelligent systems.[1][5] The idea emerged from Jungmann's frustration with fragmented healthcare documentation, inspiring a platform that turns chaos into structured insights—much like "omics" fields (genomics, proteomics) decode biological complexity.[5] Early pivotal moments include co-development with pilot customers in European healthcare settings and securing $2M pre-seed funding to accelerate its AI backbone, amid clinician shortages and rising documentation demands.[4]
Aiomics rides the AI-for-healthcare wave in Europe, where unstructured data (80% of records) fuels admin overload amid worker shortages and strict regs like the EU AI Act—timing perfectly as hospitals seek flexible, compliant tools post-failed legacy implementations.[2][4][5] Market forces favoring it include rising telemedicine, rehab needs, and demands for interoperable AI that empowers (not replaces) staff, turning data into actionable insights for better outcomes and cost savings.[1][2][4] It influences the ecosystem by pioneering an "EU-first" backbone for medtech innovation, enabling patient empowerment via contextual access and fostering efficient data flows across providers—positioning as foundational infrastructure amid Europe's push for digital health sovereignty.[3][4][5]
Aiomics is poised to expand its AI platform across Europe, deepening pilots into full deployments while enhancing patient-facing features in its Care Triad.[4] Trends like AI Act enforcement, FHIR adoption, and clinician burnout will propel demand for its compliant, time-saving co-pilot, potentially capturing share in a fragmented market.[2][3][5] Its influence may evolve from documentation specialist to broader healthcare AI enabler, blending medtech with omics-inspired insights—if it sustains user-close iteration and funding momentum. This positions aiomics to reclaim providers' focus for care, transforming fragmented systems into a unified force for European health innovation.
aiomics has raised $2.0M in total across 1 funding round.
aiomics's investors include Vorwerk Ventures, Konstantin Othmer.
aiomics has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Seed in August 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 1, 2025 | $2.0M Seed | Vorwerk Ventures, Konstantin Othmer |